Targeting CD38 with Daratumumab Suppresses B-Cell Receptor Signaling and Enhances the Activity of Ibrutinib in Waldenstrom Macroglobulinemia Cells

被引：0
|
作者：
Paulus, Aneel
Manna, Alak
Akhtar, Sharoon
Sher, Taimur
Roy, Vivek
Coleman, Morton
Novak, Anne J.
Ansell, Stephen M.
Malavasi, Fabio
Ailawadhi, Sikander
Chanan-Khan, Asher A.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1529
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Dysregulation of the B-Cell Receptor Pathway Through Alternative Splicing in Waldenstrom's Macroglobulinemia
    Tsakmaklis, Nickolas
    Kofides, Amanda
    Demos, Maria
    Xu, Lian
    Liu, Xia
    Yang, Guang
    Munshi, Manit
    Chen, Jiaji
    Guerrera, Maria Luisa
    Jimenez, Cristina
    Chan, Gloria
    Castillo, Jorge
    Treon, Steven
    Hunter, Zachary
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E335 - E335
  • [22] WALDENSTROM MACROGLOBULINEMIA CELLS WITH PLASMACYTIC-PREDOMINANT FEATURES ARE INSENSITIVE TO DISRUPTION OF B-CELL RECEPTOR SIGNALING BUT RETAIN HEIGHTENED SENSITIVITY TO PROTEOTOXIC STRESS
    Paulus, A.
    Akhtar, S.
    Wang, X.
    Wallace, P.
    Ailawadhi, S.
    Ansell, S.
    Novak, A.
    Gertz, M.
    Kyle, R.
    Martin, P.
    Coleman, M.
    Chanan-Khan, A.
    Chitta, K.
    HAEMATOLOGICA, 2015, 100 : 551 - 551
  • [23] Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
    Wyndham H Wilson
    Ryan M Young
    Roland Schmitz
    Yandan Yang
    Stefania Pittaluga
    George Wright
    Chih-Jian Lih
    P Mickey Williams
    Arthur L Shaffer
    John Gerecitano
    Sven de Vos
    Andre Goy
    Vaishalee P Kenkre
    Paul M Barr
    Kristie A Blum
    Andrei Shustov
    Ranjana Advani
    Nathan H Fowler
    Julie M Vose
    Rebecca L Elstrom
    Thomas M Habermann
    Jacqueline C Barrientos
    Jesse McGreivy
    Maria Fardis
    Betty Y Chang
    Fong Clow
    Brian Munneke
    Davina Moussa
    Darrin M Beaupre
    Louis M Staudt
    Nature Medicine, 2015, 21 : 922 - 926
  • [24] Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
    Wilson, Wyndham H.
    Young, Ryan M.
    Schmitz, Roland
    Yang, Yandan
    Pittaluga, Stefania
    Wright, George
    Lih, Chih-Jian
    Williams, P. Mickey
    Shaffer, Arthur L.
    Gerecitano, John
    de Vos, Sven
    Goy, Andre
    Kenkre, Vaishalee P.
    Barr, Paul M.
    Blum, Kristie A.
    Shustov, Andrei
    Advani, Ranjana
    Fowler, Nathan H.
    Vose, Julie M.
    Elstrom, Rebecca L.
    Habermann, Thomas M.
    Barrientos, Jacqueline C.
    McGreivy, Jesse
    Fardis, Maria
    Chang, Betty Y.
    Clow, Fong
    Munneke, Brian
    Moussa, Davina
    Beaupre, Darrin M.
    Staudt, Louis M.
    NATURE MEDICINE, 2015, 21 (08) : 922 - 926
  • [25] Activated T cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell malignancies
    Mihara, Keichiro
    Yanagihara, Kazuyoshi
    Takigahira, Misato
    Ochiya, Takahiro
    Imai, Chihaya
    Kitanaka, Akira
    Takihara, Yoshihiro
    Kimuna, Akiro
    BLOOD, 2007, 110 (11) : 696A - 696A
  • [26] Proteolysis Targeting Chimeras for BTK Efficiently Inhibit B-Cell Receptor Signaling and Can Overcome Ibrutinib Resistance in CLL Cells
    Shorer Arbel, Yamit
    Katz, Ben-Zion
    Gabizon, Ronen
    Shraga, Amit
    Bronstein, Yotam
    Kamdjou, Talia
    Globerson Levin, Anat
    Perry, Chava
    Avivi, Irit
    London, Nir
    Herishanu, Yair
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [27] SIGNALING THROUGH MURINE CD38 IS IMPAIRED IN ANTIGEN RECEPTOR-UNRESPONSIVE B-CELLS
    LUND, FE
    SOLVASON, NW
    COOKE, MP
    HEATH, AW
    GRIMALDI, JC
    PARKHOUSE, RME
    GOODNOW, CC
    HOWARD, MC
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) : 1338 - 1345
  • [28] Co-Targeting CD38 with a Chimeric Costimulatory Receptor Enhances Adoptive T Cell Therapy for Hematological Malignancies
    Katsarou, Afroditi
    Sjostrand, Maria L.
    Nianias, Alexandros
    Poels, Renee
    Zweegman, Sonja
    Mutis, Tuna
    Sadelain, Michel
    Groen, Richard W. J.
    Themeli, Maria
    MOLECULAR THERAPY, 2020, 28 (04) : 40 - 41
  • [29] CD38 is physically associated with CD49d and enhances CD49d-mediated adhesion of B-Cell chronic lymphocytic leukemia cells
    Benedetti, Dania
    Zucchetto, Antonella
    Vaisitti, Tiziana
    Del Poeta, Giovanni
    VanMeter, Amy
    Espina, Virginia
    Malavasi, Fabio
    Deaglio, Silvia
    Gattei, Valter
    CANCER RESEARCH, 2011, 71
  • [30] Therapeutic targeting of CD38 enhances temozolomide activity in glioblastoma cells and modulates their tumor microenvironment by eliciting an enhanced CD8+T cell response
    Manna, Alak
    Aulakh, Sonikpreet
    Chanan-Khan, Asher
    Paulus, Aneel
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
12345